Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Grifols Biologicals, LLC | INDUSTRY |
Not provided
Not provided
Not provided
The sublingual microcirculation is impaired in sepsis and septic shock. Sidestream dark field imaging technology has been developed into a clinical tool to help the clinician assess the microcirculation at the bedside. The ideal resuscitation fluid has not been identified. The investigators aim to use this new bedside technology to establish the microcirculation properties of two popular resuscitation fluids.
Sepsis and septic shock are diseases of the microcirculation. Recent developments in microcirculation imaging have illustrated the extent of the impairment of the microcirculation in these diseases of critical care. Heterogenous flow, stagnation and microthrombi can all be seen clearly in the sublingual region using a sidestream dark field imaging device.
One of the key treatments for sepsis and septic shock is timely administration of intravenous fluids. Which fluid is administered is a matter for debate which has not been settled by several large trials. De-resuscitation has become increasingly important as physicians realise the implications and associated risks of excess fluid administration in ICU. Avoiding excess fluid administration at the resuscitation stage is therefore desirable. One of the prevailing theories about the function of albumin or colloid resuscitation is that it remains in the the intravascular space for a longer period of time, thereby continuing to benefit the patient and avoiding administration of excess fluid. However, recently albumin was tested against crystalloid for resuscitation and was shown to be effective but with no improvement in survival.
It is possible, however, that albumin is having an initial beneficial effect at a microcirculation level. Macrohaemodynamic improvements are not necessarily matched by improvements in blood flow and oxygen delivery to cells, this has been referred to as haemodynamic incoherence.
This randomised, prospective study aims to compare crystalloid and albumin resuscitation at a microcirculation level.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Interventional 20% Albumin | Experimental | Septic patients requiring a fluid bolus randomised to receive 100ml 20% albumin as boluses until they are stable or no longer require fluid resuscitation. |
|
| Control Crystalloid | Active Comparator | Septic patients requiring a fluid bolus randomised to receive 250ml boluses of crystalloid fluid until they no longer require fluid resuscitation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 20% Albumin | Other | 100ml boluses 20% Albumin |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Microcirculation parameters in response to a fluid bolus | functional capillary density, perfused capillary density after fluid bolus Proportion Perfused vessels Microvascular Flow Index Total Vessel Density | Baseline at recruitment before fluid given, during bolus, after bolus: immediately after, 60 minutes after and 24 hours after to determine if immediate, delayed or sustained change in microcirculation parameters is influenced by fluid bolus |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of vasopressor administration | 28 days | |
| Duration of Mechanical ventilation | 28 days | |
| ICU length of stay |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St James's Hospital | Dublin | Dublin | D03 WK19 | Ireland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41892832 | Derived | Cusack R, Garduno A, Cumpf S, Reyes-Morales P, Leone M, Fernandez AB, Rodriguez A, Martin-Loeches I. Mid-Regional Pro-Adrenomedullin as a Translational Biomarker of Microcirculatory Dysfunction in Sepsis: A Prospective Observational Study. Med Sci (Basel). 2026 Mar 2;14(1):117. doi: 10.3390/medsci14010117. | |
| 40725675 | Derived |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D012772 | Shock, Septic |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D000418 | Albumins |
| D000077324 | Crystalloid Solutions |
| ID | Term |
|---|---|
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Crystalloid |
| Other |
100ml bolus of crystalloid |
|
| though to stud completion; up to 1 year |
| 28 day mortality | 28 days |
| Cusack R, Rodriguez A, Cantan B, Miskolci O, Connolly E, Zilahi G, Coakley JD, Martin-Loeches I. Albumin Enhances Microvascular Reactivity in Sepsis: Insights from Near-Infrared Spectroscopy and Vascular Occlusion Testing. J Clin Med. 2025 Jul 14;14(14):4982. doi: 10.3390/jcm14144982. |
| 40020556 | Derived | Cusack RAF, Rodriguez A, Cantan B, Garduno A, Connolly E, Zilahi G, Coakley JD, Martin-Loeches I. Microcirculation properties of 20 % albumin in sepsis; a randomised controlled trial. J Crit Care. 2025 Jun;87:155039. doi: 10.1016/j.jcrc.2025.155039. Epub 2025 Feb 27. |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |
| D004364 |
| Pharmaceutical Preparations |